Works matching AU Nasu, Yasutomo

Results: 111
    1

    Efficacy and safety of 3 day versus 7 day cefditoren pivoxil regimens for acute uncomplicated cystitis: multicentre, randomized, open-label trial.

    Published in:
    2017
    By:
    • Takuya Sadahira;
    • Koichiro Wada;
    • Motoo Araki;
    • Ayano Ishii;
    • Atsushi Takamoto;
    • Yasuyuki Kobayashi;
    • Masami Watanabe;
    • Toyohiko Watanabe;
    • Yasutomo Nasu;
    • Hiromi Kumon;
    • Sadahira, Takuya;
    • Wada, Koichiro;
    • Araki, Motoo;
    • Ishii, Ayano;
    • Takamoto, Atsushi;
    • Kobayashi, Yasuyuki;
    • Watanabe, Masami;
    • Watanabe, Toyohiko;
    • Nasu, Yasutomo;
    • Kumon, Hiromi
    Publication type:
    journal article
    2
    3
    4
    5
    6
    7

    Expression of tumor suppressor REIC/Dkk-3 by a newly improved adenovirus vector with insertion of a hTERT promoter at the 3'-side of the transgene.

    Published in:
    Oncology Letters, 2017, v. 14, n. 1, p. 1041, doi. 10.3892/ol.2017.6201
    By:
    • RIE KINOSHITA;
    • HITOSHI MURATA;
    • KEN‑ICHI YAMAMOTO;
    • CHEN YOUYI;
    • MIYOKO KUBO;
    • NAM‑HO HUH;
    • MASAKIYO SAKAGUCHI;
    • KENJI SAITO;
    • PUTRANTO, ENDY WIDYA;
    • WINARSA RUMA, I. MADE;
    • SUMARDIKA, I. WAYAN;
    • HIROMI KUMON;
    • TAKUYA SADAHIRA;
    • YASUTOMO NASU;
    • MASAMI WATANABE;
    • JUNICHIRO FUTAMI;
    • KEN KATAOKA;
    • YUSUKE INOUE;
    • YOSHIHIKO SAKAGUCHI
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19

    Significance of UGT1A6, UGT1A9, and UGT2B7 genetic variants and their mRNA expression in the clinical outcome of renal cell carcinoma.

    Published in:
    Molecular & Cellular Biochemistry, 2023, v. 478, n. 8, p. 1779, doi. 10.1007/s11010-022-04637-4
    By:
    • Matsumoto, Jun;
    • Nishimoto, Anzu;
    • Watari, Shogo;
    • Ueki, Hideo;
    • Shiromizu, Shoya;
    • Iwata, Naohiro;
    • Takeda, Tatsuaki;
    • Ushio, Soichiro;
    • Kajizono, Makoto;
    • Fujiyoshi, Masachika;
    • Koyama, Toshihiro;
    • Araki, Motoo;
    • Wada, Koichiro;
    • Zamami, Yoshito;
    • Nasu, Yasutomo;
    • Ariyoshi, Noritaka
    Publication type:
    Article
    20

    DNA methylation status of REIC/Dkk- 3 gene in human malignancies.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2012, v. 138, n. 5, p. 799, doi. 10.1007/s00432-012-1158-6
    By:
    • Hayashi, Tatsuro;
    • Asano, Hiroaki;
    • Toyooka, Shinichi;
    • Tsukuda, Kazunori;
    • Soh, Junichi;
    • Shien, Tadahiko;
    • Taira, Naruto;
    • Maki, Yuho;
    • Tanaka, Norimitsu;
    • Doihara, Hiroyoshi;
    • Nasu, Yasutomo;
    • Huh, Nam-ho;
    • Miyoshi, Shinichiro
    Publication type:
    Article
    21

    Mixed 20-peptide cancer vaccine in combination with docetaxel and dexamethasone for castration-resistant prostate cancer: a randomized phase II trial.

    Published in:
    Cancer Immunology, Immunotherapy, 2020, v. 69, n. 5, p. 847, doi. 10.1007/s00262-020-02498-8
    By:
    • Noguchi, Masanori;
    • Arai, Gaku;
    • Egawa, Shin;
    • Ohyama, Chikara;
    • Naito, Seiji;
    • Matsumoto, Kazumasa;
    • Uemura, Hirotsugu;
    • Nakagawa, Masayuki;
    • Nasu, Yasutomo;
    • Eto, Masatoshi;
    • Suekane, Shigetaka;
    • Sasada, Tetsuro;
    • Shichijo, Shigeki;
    • Yamada, Akira;
    • Kakuma, Tatsuyuki;
    • Itoh, Kyogo
    Publication type:
    Article
    22

    A randomized phase II trial of personalized peptide vaccine plus low dose estramustine phosphate (EMP) versus standard dose EMP in patients with castration resistant prostate cancer.

    Published in:
    Cancer Immunology, Immunotherapy, 2010, v. 59, n. 7, p. 1001, doi. 10.1007/s00262-010-0822-4
    By:
    • Noguchi, Masanori;
    • Kakuma, Tatsuyuki;
    • Uemura, Hirotsugu;
    • Nasu, Yasutomo;
    • Kumon, Hiromi;
    • Hirao, Yasuhiko;
    • Moriya, Fukuko;
    • Suekane, Shigetaka;
    • Matsuoka, Kei;
    • Komatsu, Nobukazu;
    • Shichijo, Shigeki;
    • Yamada, Akira;
    • Itoh, Kyogo
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29

    Maintenance therapy with bacillus Calmette-Guérin Connaught strain clearly prolongs recurrence-free survival following transurethral resection of bladder tumour for non-muscle-invasive bladder cancer.

    Published in:
    BJU International, 2011, v. 108, n. 2, p. 187, doi. 10.1111/j.1464-410X.2010.09891.x
    By:
    • Hinotsu, Shiro;
    • Akaza, Hideyuki;
    • Naito, Seiji;
    • Ozono, Seiichiro;
    • Sumiyoshi, Yoshiteru;
    • Noguchi, Sumio;
    • Yamaguchi, Akito;
    • Nagamori, Satoshi;
    • Terai, Akito;
    • Nasu, Yasutomo;
    • Kume, Haruki;
    • Tomita, Yoshihiko;
    • Tanaka, Yoshinori;
    • Samma, Shoji;
    • Uemura, Hirotsugu;
    • Koga, Hirofumi;
    • Tsushima, Tomoyasu
    Publication type:
    Article
    30
    31

    Genome-wide association study identified SNP on 15q24 associated with bladder cancer risk in Japanese population.

    Published in:
    Human Molecular Genetics, 2015, v. 24, n. 4, p. 1177, doi. 10.1093/hmg/ddu512
    By:
    • Koichi Matsuda;
    • Atsushi Takahashi;
    • Middlebrooks, Candace D.;
    • Wataru Obara;
    • Yasutomo Nasu;
    • Keiji Inoue;
    • Kenji Tamura;
    • Ichiro Yamasaki;
    • Yoshio Naya;
    • Chizu Tanikawa;
    • Ri Cui;
    • Figueroa, Jonine D.;
    • Silverman, Debra T.;
    • Rothman, Nathaniel;
    • Mikio Namiki;
    • Yoshihiko Tomita;
    • Hiroyuki Nishiyama;
    • Kenjiro Kohri;
    • Takashi Deguchi;
    • Masayuki Nakagawa
    Publication type:
    Article
    32
    33
    34
    35
    36

    Prognostic value of the systemic immune-inflammation index in non-muscle invasive bladder cancer.

    Published in:
    World Journal of Urology, 2021, v. 39, n. 12, p. 4355, doi. 10.1007/s00345-021-03740-3
    By:
    • Katayama, Satoshi;
    • Mori, Keiichiro;
    • Pradere, Benjamin;
    • Laukhtina, Ekaterina;
    • Schuettfort, Victor M.;
    • Quhal, Fahad;
    • Motlagh, Reza Sari;
    • Mostafaei, Hadi;
    • Grossmann, Nico C.;
    • Rajwa, Pawel;
    • Moschini, Marco;
    • Mathieu, Romain;
    • Abufaraj, Mohammad;
    • D'Andrea, David;
    • Compérat, Eva;
    • Haydter, Martin;
    • Egawa, Shin;
    • Nasu, Yasutomo;
    • Shariat, Shahrokh F.
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43
    44
    45

    Feasible kidney donation with living marginal donors, including diabetes mellitus.

    Published in:
    Immunity, Inflammation & Disease, 2021, v. 9, n. 3, p. 1061, doi. 10.1002/iid3.470
    By:
    • Yoshinaga, Kasumi;
    • Araki, Motoo;
    • Wada, Koichiro;
    • Sekito, Takanori;
    • Watari, Shogo;
    • Maruyama, Yuki;
    • Mitsui, Yosuke;
    • Sadahira, Takuya;
    • Kubota, Risa;
    • Nishimura, Shingo;
    • Edamura, Kohei;
    • Kobayashi, Yasuyuki;
    • Tanabe, Katsuyuki;
    • Takeuchi, Hidemi;
    • Kitagawa, Masashi;
    • Kitamura, Shinji;
    • Wada, Jun;
    • Watanabe, Masami;
    • Watanabe, Toyohiko;
    • Nasu, Yasutomo
    Publication type:
    Article
    46
    47
    48

    Synergistic anti-pancreatic cancer immunological effects by treatment with reduced expression in immortalized cells/dickkopf-3 protein and peripheral blood mononuclear cells.

    Published in:
    Journal of Gastroenterology & Hepatology, 2016, v. 31, n. 6, p. 1154, doi. 10.1111/jgh.13259
    By:
    • Uchida, Daisuke;
    • Shiraha, Hidenori;
    • Kato, Hironari;
    • Sawahara, Hiroaki;
    • Nagahara, Teruya;
    • Iwamuro, Masaya;
    • Kataoka, Junro;
    • Horiguchi, Shigeru;
    • Watanabe, Masami;
    • Takaki, Akinobu;
    • Nouso, Kazuhiro;
    • Nasu, Yasutomo;
    • Kumon, Hiromi;
    • Yamamoto, Kazuhide
    Publication type:
    Article
    49
    50